All news
When Eating Becomes Difficult: Students Rethink Cooking During Cancer Treatment
29 October 2026When cancer treatment makes eating difficult, small changes can make a difference. Discover how students from Croatia and North Macedonia are combi...
New Hope for Pancreatic Cancer as Daraxonrasib Nears EU Approval
28 October 2026Daraxonrasib has received a positive European recommendation for previously treated metastatic pancreatic cancer, following trial results showing l...
Strengthening Patient Representation at UEG Week 2026
28 October 2026At UEG Week 2026 in Barcelona, DiCE strengthened patient representation, championed cancer prevention and early detection, and shared new TOGAS res...
The EU Biotech Act: What an Extra Year of IP Rights Could Mean for Patients
28 October 2026Could an extra year of protection for some medicines bring new cancer treatments closer, or delay more affordable options? As Europe debates the EU...
From the Other Side of the Laboratory Door
28 September 2026After undergoing pancreatic cancer treatment, Pamela stepped inside the laboratory through VOICE-Ireland. She reflects on learning the science behi...
Funding Member Organisations to Make a Greater Impact Across Europe
28 September 2026DiCE’s 2026 operational grants and Wolfram Nolte Memorial Award offer Member Organisations flexible funding to strengthen patient-led work across...
Strengthening the Voice of Liver Cancer Patients: Welcoming the Croatian Rare Liver Foundation to DiCE
25 September 2026The Croatian Rare Liver Foundation has joined DiCE, strengthening the voice of people affected by liver cancer in Croatia. Its expertise in patient...
How US Drug Pricing Could Affect Access to Cancer Medicines in Europe
24 September 2026US drug pricing reforms could influence when and where cancer medicines reach European patients. Evidence remains inconclusive, but concerns over d...
When Every Month Matters, Innovation Must Reach Patients
24 September 2026Pamela reflects on the promise of daraxonrasib for people living with pancreatic cancer, the urgent need to turn scientific progress into timely an...